US.LH · Labcorp

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.4,
      "details": {
        "atrPct": 2.2638310708898945,
        "turnoverUsdM": 172.59216,
        "liquidityPoints": 0.4,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.LH",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 316.4908,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 2,
        "rsi_score": 3,
        "macd_score": 1.5,
        "volume_score": 1
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.1,
      "stop_loss_percent": 4.5,
      "take_profit_price": 348.3728,
      "target_multiplier": 1.9,
      "technical_strength": 1.78,
      "take_profit_percent": 5.1
    },
    "positionPoints": 1.4,
    "stopLossPoints": 2.4,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 4.527662141779789,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 58.8,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 55.8,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 3
  },
  "market": {
    "ma20": 329.0015,
    "ma50": 305.3204,
    "close": 331.5,
    "prevClose": 331.66,
    "avgVolume20": 581772,
    "volumeRatio": 0.89,
    "changePercent": -0.05
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 3,
    "details": {
      "ret_5d": -0.014975960807750655,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 3,
      "vcp_bonus": 0,
      "vol_ratio": 0.9011588157405084,
      "ret_points": 0,
      "vol_points": 0,
      "range_ratio": 0.8879330772422562,
      "volat_points": 0,
      "day_range_pct": 0.01850681749622933,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 3,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 58.8,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 3.3,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 66,
        "contribution": 3.3
      },
      {
        "raw": 10,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 50,
        "contribution": 10
      },
      {
        "raw": 11.2,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 74.67,
        "contribution": 11.2
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 7.2,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 72,
        "contribution": 7.2
      },
      {
        "raw": 18.1,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 60.33,
        "contribution": 18.1
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 55.8,
    "details": [
      "基本面分析總分: 3.3/5分",
      "資金流分析總分: 10/20分",
      "市場環境分析總分: 11.2/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 7.2/10分",
      "技術信號分析總分: 18.1/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.3,
      "資金流": 10,
      "市場環境": 11.2,
      "情緒分析": 4,
      "技術信號": 18.1,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "一般",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.2,
          "epsPoints": 0.6,
          "roePoints": 0.4,
          "debtPoints": 0.4,
          "marginPoints": 0,
          "turnoverUsdM": 172.59216,
          "volumePoints": 0.5,
          "revenuePoints": 0,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 1.6,
          "mfiPoints": 3.2,
          "obvPoints": 0.8,
          "vwapPoints": 2.4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.LH",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "良好",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.2
            }
          },
          "trend": {
            "score": 3.4,
            "details": {
              "qqq": {
                "ma20": 717.7140015000001,
                "ma50": 711.03339964,
                "name": "QQQ",
                "close": 717.66998,
                "points": 1.4
              },
              "spy": {
                "ma20": 769.2064939,
                "ma50": 756.1394004199999,
                "name": "SPY",
                "close": 773.16998,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 2.2638310708898945,
          "atrPoints": 3,
          "cciPoints": 2.4,
          "vixPoints": 2.4,
          "marketTrendPoints": 3.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 5,
              "negativeHits": 0,
              "positiveHits": 2,
              "sentimentScoreRaw": 1
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 141364799,
                "url": "https://finnhub.io/api/news?id=31373309b32b11664a69313cdfde6a304286bcf2a7d2f7f46816cf13cc737438",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings (NYSE: LH) introduced the Elecsys pTau-217 blood test, the first FDA-cleared single biomarker test for Alzheimer’s disease, expanding access through primary and specialty care. The Elecsys pTau-217 test is positioned to support clinical assessment of cognitive decline with a minimally invasive blood draw instead of more invasive procedures. Labcorp announced a long-term alliance with the National Association of Community Health Centers to support clinical leadership and...",
                "category": "company",
                "datetime": 1787887077,
                "headline": "Labcorp Holdings (LH) Unveiled The First FDA Cleared Single Biomarker Alzheimer’s Blood Test"
              },
              {
                "id": 141328528,
                "url": "https://finnhub.io/api/news?id=41d4184e9828e30deff21e42d2056e1128eedab4a275a35a6c0cb91c26459fec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Over the past six months, Labcorp has been a great trade, beating the S&P 500 by 9.5%. Its stock price has climbed to $339.34, representing a healthy 20% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1787671604,
                "headline": "3 Reasons LH is Risky and 1 Stock to Buy Instead"
              },
              {
                "id": 141195498,
                "url": "https://finnhub.io/api/news?id=52a9e9c710389d8e328c113ec8d19bb6fe8cdf20776be938d5fee35bc4b11809",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings (LH) is in focus after a series of oncology diagnostics approvals and launches, including the PGDx elio tissue complete CDx for advanced melanoma and nationwide access to Roche's VENTANA PTEN RxDx Assay for prostate cancer. See our latest analysis for Labcorp Holdings. Labcorp Holdings has attracted more attention in recent months, with oncology diagnostics approvals and stronger earnings updates sitting alongside a 30 day share price return of 16.48% and a 1 year total...",
                "category": "company",
                "datetime": 1786554523,
                "headline": "Is Labcorp Holdings (LH) Fully Priced Following Oncology Approvals And Raised Outlook?"
              },
              {
                "id": 141195499,
                "url": "https://finnhub.io/api/news?id=113fd9a31a9520a3488b53c1dc4d4d6b3879247f5450043b998c69734cadd53d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "In late July and early August 2026, Labcorp reported higher second-quarter and year-to-date earnings, raised its 2026 revenue growth guidance, completed a large share repurchase program, and expanded its precision oncology offering by making Roche's FDA-approved VENTANA PTEN (SP218) RxDx Assay available nationwide to help guide prostate cancer treatment decisions. Together with the recent FDA approval of its PGDx elio tissue complete CDx for advanced melanoma, these developments reinforce...",
                "category": "company",
                "datetime": 1786513280,
                "headline": "Did Stronger Guidance, Buybacks and New Oncology Tests Just Shift Labcorp Holdings' (LH) Investment Narrative?"
              },
              {
                "id": 141104982,
                "url": "https://finnhub.io/api/news?id=295204cd4af9efb6610e72a4dabb7c24f5d072f220625e367e538daf94479f5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Specialty testing and Central Labs fueled revenue growth and margin expansion.",
                "category": "company",
                "datetime": 1785802612,
                "headline": "Labcorp (LH) Q2 2026 Earnings Call Transcript"
              }
            ],
            "raw_source": [
              {
                "id": 141362285,
                "url": "https://finnhub.io/api/news?id=7cc64918f3b60782ab2fbcbefa34e6aa0b5f06d064dc3153c595d7e299f4f42e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Its deepest fall inside a market shock is not its deepest fall, and that gap is what a holder should size for.",
                "category": "company",
                "datetime": 1788208182,
                "headline": "Market Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest"
              },
              {
                "id": 141364803,
                "url": "https://finnhub.io/api/news?id=81fd2d01385ccdaa2f54d388659f34035e4017a6ddcf58f461004c4142cd376d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory solutions, today announced enhancements to the digital experience of Labcorp Global Trial Connect™, the company's portfolio of clinical trial services, data and technology that enhances and accelerates delivery. The newly redesigned platform introduces new capabilities across the Labcorp Sponsor™ and Labcorp Investigator™ portal experiences of Global Trial Connect, providing greater visibility across studies, simplify",
                "category": "company",
                "datetime": 1788177600,
                "headline": "Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity"
              },
              {
                "id": 141364798,
                "url": "https://finnhub.io/api/news?id=22001312f7ec803e2ef7a0cae3411b2f7deaa54910259b1aa3250d27030abf9f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, Sept. 15, at 11:30 a.m. ET.",
                "category": "company",
                "datetime": 1787923800,
                "headline": "Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference"
              },
              {
                "id": 141364799,
                "url": "https://finnhub.io/api/news?id=31373309b32b11664a69313cdfde6a304286bcf2a7d2f7f46816cf13cc737438",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings (NYSE: LH) introduced the Elecsys pTau-217 blood test, the first FDA-cleared single biomarker test for Alzheimer’s disease, expanding access through primary and specialty care. The Elecsys pTau-217 test is positioned to support clinical assessment of cognitive decline with a minimally invasive blood draw instead of more invasive procedures. Labcorp announced a long-term alliance with the National Association of Community Health Centers to support clinical leadership and...",
                "category": "company",
                "datetime": 1787887077,
                "headline": "Labcorp Holdings (LH) Unveiled The First FDA Cleared Single Biomarker Alzheimer’s Blood Test"
              },
              {
                "id": 141328527,
                "url": "https://finnhub.io/api/news?id=2c6fa2557dbaec4227f8dbd5021b3fcd3bd488b0437bacab7dbbf50e03b31ffb",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Do Wall Street analysts favor Labcorp’s stock, given its solid performance?",
                "category": "company",
                "datetime": 1787755302,
                "headline": "Are Wall Street Analysts Bullish on Labcorp Holdings Stock?"
              },
              {
                "id": 141328528,
                "url": "https://finnhub.io/api/news?id=41d4184e9828e30deff21e42d2056e1128eedab4a275a35a6c0cb91c26459fec",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Over the past six months, Labcorp has been a great trade, beating the S&P 500 by 9.5%. Its stock price has climbed to $339.34, representing a healthy 20% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
                "category": "company",
                "datetime": 1787671604,
                "headline": "3 Reasons LH is Risky and 1 Stock to Buy Instead"
              },
              {
                "id": 141328529,
                "url": "https://finnhub.io/api/news?id=1bc29ddfb3cac19c10a5e8e6813ba6adf0b2ec574897211762477575abdd5086",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "DHR's Biotechnology segment grows as China demand, bioprocessing and improving discovery markets offset regional headwinds.",
                "category": "company",
                "datetime": 1787666640,
                "headline": "Danaher Rides on Strength in Biotechnology Segment: Will It Sustain?"
              },
              {
                "id": 141328530,
                "url": "https://finnhub.io/api/news?id=987bec09fcd486813ecb7d3a7687216add4739a533d76a32cbe7bc626b57e328",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "LH's specialty-testing expansion, strategic partnerships and buybacks support growth, while reimbursement and cost pressures pose risks.",
                "category": "company",
                "datetime": 1787664000,
                "headline": "Should You Continue to Hold Labcorp Stock in Your Portfolio?"
              },
              {
                "id": 141313625,
                "url": "https://finnhub.io/api/news?id=bf0775da347333c805e2171fe144b86c4c7a909f48cddbae25b312b5df9f684d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys® pTau-217 test following clearance by the U.S. Food and Drug Administration (FDA). Developed by Roche Diagnostics, the blood test aids in identifying amyloid pathology associated with Alzheimer's disease in individuals 55 and older with signs, symptoms or complaints of cognitive decline. Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test",
                "category": "company",
                "datetime": 1787569320,
                "headline": "Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings"
              },
              {
                "id": 141311514,
                "url": "https://finnhub.io/api/news?id=ea8b7c842e72dc4a35a5969cc5038e4bcce5289bd7456967e5649d34ae7c971c",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test to both rule in and rule out amyloid pathology across specialty and primary care settingsMeasures phosphorylated Tau 217 (pTau-217), an",
                "category": "company",
                "datetime": 1787555281,
                "headline": "Labcorp To Offer Elecsys pTau-217 Test Following Clearance By FDA"
              },
              {
                "id": 141275203,
                "url": "https://finnhub.io/api/news?id=089773ba910b7d77165aa048f75b768edf24f1414da740123cd9e15d62e665de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "The gap between its revenue multiple and its cash multiple is margin, and the company is spending it on purpose.",
                "category": "company",
                "datetime": 1787257290,
                "headline": "Hims & Hers Health Stock Trades Below The Market On Revenue And Above It On Cash"
              },
              {
                "id": 141266861,
                "url": "https://finnhub.io/api/news?id=9cedcdf4c43cd7438e7b70ae9a03e3c4bf570d0f0bd5b655596aaaef72271d12",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "IDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international expansion offset softer U.S. veterinary traffic.",
                "category": "company",
                "datetime": 1787243820,
                "headline": "IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve"
              },
              {
                "id": 141283687,
                "url": "https://finnhub.io/api/news?id=c1083eb5d78d2494cc5298cb1e9b87db833a0270edea2b3e80d13132b8c82147",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "OPKO Health's 12.4% monthly gain is backed by narrower losses and better margins, though profitability and clinical execution remain key risks.",
                "category": "company",
                "datetime": 1787160900,
                "headline": "OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going?"
              },
              {
                "id": 141283677,
                "url": "https://finnhub.io/api/news?id=e5c485442820baef6b2efbdde6716d59d47ff872afaf6e93bbdacc8bd228238b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and the National Association of Community Health Centers (NACHC) today announced a strategic alliance to strengthen leadership development, support practice improvement and advance community health initiatives across the nation's Community Health Center (CHC) network. As part of the collaboration, the organizations are launching the NACHC Leadership Exchange for Chief Medical Officers, designed to support cu",
                "category": "company",
                "datetime": 1787054400,
                "headline": "Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health"
              },
              {
                "id": 141249550,
                "url": "https://finnhub.io/api/news?id=e4a4007233f345246016d931e5f8bdf59aed8a125f2b5b12aef7d10c07478b65",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "Collaboration will support leadership development, practice improvement and innovation across the nation's Community Health CentersBURLINGTON, N.C. and BETHESDA, Md., Aug. 18, 2026 /PRNewswire/ -- Labcorp (NYSE:LH),",
                "category": "company",
                "datetime": 1787036885,
                "headline": "Labcorp And NACHC Announce Strategic Alliance To Support Practice Improvement And Advance Community Health Initiatives Across Community Health Center Network"
              },
              {
                "id": 141283671,
                "url": "https://finnhub.io/api/news?id=bc11bca6e6fed5f8b9cc8192451e1dd125d0d9e8ada4eb2d22092d7b3fd87f6d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced it will host an Investor Day on Thursday, September 10, 2026, from 9 a.m. to noon ET.",
                "category": "company",
                "datetime": 1786971600,
                "headline": "Labcorp to Host Investor Day on September 10, 2026"
              },
              {
                "id": 141231125,
                "url": "https://finnhub.io/api/news?id=20166a2b2acd2263cfdbcc99fc419c59e514054bea615fc73fdbae8d84095aeb",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445262091/image_1445262091.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "LH",
                "summary": "Healthcare sector valuation check: equipment undervalued, providers near baseline, pharma/biotech overvalued. Learn more about IHF ETF here.",
                "category": "company",
                "datetime": 1786867596,
                "headline": "IHF: Healthcare Dashboard For August"
              },
              {
                "id": 141206752,
                "url": "https://finnhub.io/api/news?id=659ee02b225f8ed4a921b6c898a8d79914a526a79eab67069f99e681ffb2582e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Bio-Techne's Q4 revenues beat estimates as Diagnostics and Spatial Biology deliver strong organic growth, while its Merck deal remains in focus.",
                "category": "company",
                "datetime": 1786626060,
                "headline": "TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises"
              },
              {
                "id": 141202443,
                "url": "https://finnhub.io/api/news?id=884f7cde5cf80530f3f3b7a4222766c9d5b1611dd2c9927a81ff8dbcb1403238",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Schechter maintains a $33 million stake after this pre-scheduled sale under a Rule 10b5-1 plan.",
                "category": "company",
                "datetime": 1786570501,
                "headline": "Labcorp CEO Adam Schechter Sells 4,669 Shares for $1.5 Million"
              },
              {
                "id": 141195498,
                "url": "https://finnhub.io/api/news?id=52a9e9c710389d8e328c113ec8d19bb6fe8cdf20776be938d5fee35bc4b11809",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp Holdings (LH) is in focus after a series of oncology diagnostics approvals and launches, including the PGDx elio tissue complete CDx for advanced melanoma and nationwide access to Roche's VENTANA PTEN RxDx Assay for prostate cancer. See our latest analysis for Labcorp Holdings. Labcorp Holdings has attracted more attention in recent months, with oncology diagnostics approvals and stronger earnings updates sitting alongside a 30 day share price return of 16.48% and a 1 year total...",
                "category": "company",
                "datetime": 1786554523,
                "headline": "Is Labcorp Holdings (LH) Fully Priced Following Oncology Approvals And Raised Outlook?"
              },
              {
                "id": 141195499,
                "url": "https://finnhub.io/api/news?id=113fd9a31a9520a3488b53c1dc4d4d6b3879247f5450043b998c69734cadd53d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "In late July and early August 2026, Labcorp reported higher second-quarter and year-to-date earnings, raised its 2026 revenue growth guidance, completed a large share repurchase program, and expanded its precision oncology offering by making Roche's FDA-approved VENTANA PTEN (SP218) RxDx Assay available nationwide to help guide prostate cancer treatment decisions. Together with the recent FDA approval of its PGDx elio tissue complete CDx for advanced melanoma, these developments reinforce...",
                "category": "company",
                "datetime": 1786513280,
                "headline": "Did Stronger Guidance, Buybacks and New Oncology Tests Just Shift Labcorp Holdings' (LH) Investment Narrative?"
              },
              {
                "id": 141202446,
                "url": "https://finnhub.io/api/news?id=bab940f55a7015d88f60068e2a5c3a85f4cdee542e259b301b823c86d91a00e2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "ALC's Q2 earnings and sales beat estimates as equipment and ocular health gains lift results, while the company raises its 2026 EPS outlook.",
                "category": "company",
                "datetime": 1786454220,
                "headline": "Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs"
              },
              {
                "id": 141175551,
                "url": "https://finnhub.io/api/news?id=335ee49202be9ffff32971915dd2c0726283f0b283c39a280888d2ccb6cbefef",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "LH enters late 2026 with stronger growth, margin gains and raised guidance, but a rich valuation and cost risks support a measured view.",
                "category": "company",
                "datetime": 1786373040,
                "headline": "Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?"
              },
              {
                "id": 141175552,
                "url": "https://finnhub.io/api/news?id=eee9f1f73ba5090380f2701c2893296c2b81648f037f5e89f4a44803cadf2233",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Insulet's Q2 results beat estimates on strong Omnipod demand and wider margins, but its 2026 revenue outlook takes a hit.",
                "category": "company",
                "datetime": 1786368120,
                "headline": "PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Down"
              },
              {
                "id": 141173754,
                "url": "https://finnhub.io/api/news?id=0f7603567957d6263f1c0c28e1b96d52b004f1603691cc3fddfe295396d66f4f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that the U.S. Food and Drug Administration (FDA) has approved Labcorp's PGDx elio® tissue complete CDx as a companion diagnostic to help identify patients with advanced melanoma with certain BRAF variants who may benefit from treatment with FDA-approved targeted therapiesi.",
                "category": "company",
                "datetime": 1786359600,
                "headline": "Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma"
              },
              {
                "id": 141149648,
                "url": "https://finnhub.io/api/news?id=23ea5ce12ca989bc8194b69e7daad6302e9ee390a675376aa73d23dc8c9d4466",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Prestige Consumer's Q1 earnings and revenues outpace estimates as acquisitions boost its fiscal 2027 outlook despite margin pressure.",
                "category": "company",
                "datetime": 1786115820,
                "headline": "PBH Stock Up on Q1 Earnings and Revenue Beat, Fiscal '27 View Raised"
              },
              {
                "id": 141149640,
                "url": "https://finnhub.io/api/news?id=9330c5d081238104a84cc1a9ddf25b5c9eb1eb96172fe7a4c6eb81db3d1c6b84",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Resmed's Q4 earnings and revenues beat estimates, but shares fall as fiscal 2027 revenue guidance trails the consensus mark.",
                "category": "company",
                "datetime": 1786115520,
                "headline": "RMD Stock Down Despite Q4 Earnings Beat, Revenues Rise Y/Y"
              },
              {
                "id": 141148177,
                "url": "https://finnhub.io/api/news?id=d125aba8d6bfc00d706132d273626c8dadaedc5c85eb89d47c934fce7ab53293",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "LH shares surged 14% in a month as stronger earnings, margin gains and growth collide with a valuation above the company's five-year median.",
                "category": "company",
                "datetime": 1786113360,
                "headline": "Labcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuation"
              },
              {
                "id": 141122630,
                "url": "https://finnhub.io/api/news?id=f0d3f50c1dc72e766cb1b44a80ca4169797e7933306849ac32ca38bbb7329306",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "CVS beats Q2 earnings and revenue estimates as stronger segment performance lifts results and prompts raised 2026 guidance, sending shares higher.",
                "category": "company",
                "datetime": 1785939600,
                "headline": "CVS Health Q2 Earnings and Revenues Top Estimates, Stock Climbs"
              },
              {
                "id": 141120805,
                "url": "https://finnhub.io/api/news?id=c7bd52b475fb75372a286906251e0256b3c53c47c1e6c7d37dbd30857513f8f1",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "LH",
                "summary": "As we await the opening of the US market on Wednesday, let's delve into the pre-market session and discover the S&P500 top gainers and losers shaping the early market sentiment.",
                "category": "company",
                "datetime": 1785933301,
                "headline": "Wondering what's happening in today's S&P500  pre-market session?"
              },
              {
                "id": 141111550,
                "url": "https://finnhub.io/api/news?id=de33b8a0123d2b292054ba1f29716341249c010c55f9d5ee0e321353a5057f28",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2212125572/image_2212125572.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "LH",
                "summary": "OPKO Health's Q2 results: IP revenue surged on Nicoya deal and FY2026 guidance rose. Click for this OPK stock update.",
                "category": "company",
                "datetime": 1785851748,
                "headline": "OPKO Health: Mazdutide And MDX-2201 Could Change Everything"
              },
              {
                "id": 141110312,
                "url": "https://finnhub.io/api/news?id=01e5837a924347cd1bedd5dda28d8136eee81b885372098288f763d19df0933a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Henry Schein tops Q2 earnings and revenue estimates as internal sales growth accelerates and management raises its 2026 outlook, lifting shares.",
                "category": "company",
                "datetime": 1785850380,
                "headline": "HSIC Surpasses Q2 Earnings and Revenue Estimates, Stock Climbs"
              },
              {
                "id": 141107902,
                "url": "https://finnhub.io/api/news?id=24103420de0414db7e1d1dac26623ef2061b74e82104d0586b92f8eb6de2ca2f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced the nationwide availability of Roche's VENTANA® PTEN (SP218) RxDx Assay, the first immunohistochemistry (IHC) companion diagnostic test approved by the U.S. Food and Drug Administration (FDA) to determine PTEN protein loss, also known as PTEN deficiency, in tumors of patients with prostate adenocarcinoma. The assay helps identify patients who may be eligible for treatment with AstraZeneca's TRUQAP®",
                "category": "company",
                "datetime": 1785841200,
                "headline": "Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer"
              },
              {
                "id": 141113826,
                "url": "https://finnhub.io/api/news?id=cb7569dd8f4e97eb03cb01e03d6d0b6d8c8a2fb0337ecd499476112b3e481b16",
                "image": "",
                "source": "Benzinga",
                "related": "LH",
                "summary": "The assay helps identify patients who may be eligible for treatment with AstraZeneca's TRUQAP® (capivasertib) in combination with abiraterone acetate and prednisone.",
                "category": "company",
                "datetime": 1785827584,
                "headline": "Labcorp Announces Availability of Roche's Ventana Pten RxDx Assay, First Immunohistochemistry Companion Diagnostic Test Approved By FDA To Determine Pten Protein Loss In Prostate Adenocarcinoma Patients"
              },
              {
                "id": 141104982,
                "url": "https://finnhub.io/api/news?id=295204cd4af9efb6610e72a4dabb7c24f5d072f220625e367e538daf94479f5c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "LH",
                "summary": "Specialty testing and Central Labs fueled revenue growth and margin expansion.",
                "category": "company",
                "datetime": 1785802612,
                "headline": "Labcorp (LH) Q2 2026 Earnings Call Transcript"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 5,
            "negative_hits": 0,
            "positive_hits": 2,
            "recomputed_at_score": true,
            "sentiment_score_raw": 1,
            "source_article_count": 35,
            "discarded_article_count": 30
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 18.1,
        "grade": "一般",
        "items": {
          "bbPoints": 3,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 2.2,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 2.2,
            "vcp_reason": "波幅收縮(16.7%→4.6%)；跌縮量(近10日4日)；站上MA50；Ready=Y；Confirm=N",
            "vcp_metrics": {
              "up_days": 4,
              "vol_ref": 714326.6666666666,
              "down_days": 5,
              "vcp_ready": true,
              "above_ma50": true,
              "avg_vol_10": 658600,
              "avg_vol_20": 577745,
              "avg_vol_30": 714326.6666666666,
              "range_pct_10": 0.04612361990950213,
              "range_pct_20": 0.0889894419306184,
              "range_pct_30": 0.16681746606334835,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": true,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9219871394040076,
              "dist_to_20d_high": 0.030134553251449717,
              "down_shrink_days": 4,
              "breakout_level_20d": 341.79999,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.2764915509026306
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0.6,
          "volumePointsTechnical": 0.8
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "良好",
        "items": {
          "position": {
            "score": 1.4,
            "details": {
              "atrPct": 2.2638310708898945,
              "turnoverUsdM": 172.59216,
              "liquidityPoints": 0.4,
              "volatilityPoints": 1
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.LH",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 316.4908,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 2,
              "rsi_score": 3,
              "macd_score": 1.5,
              "volume_score": 1
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1.1,
            "stop_loss_percent": 4.5,
            "take_profit_price": 348.3728,
            "target_multiplier": 1.9,
            "technical_strength": 1.78,
            "take_profit_percent": 5.1
          },
          "positionPoints": 1.4,
          "stopLossPoints": 2.4,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 4.527662141779789,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 64.29,
    "atr": {
      "atr": 7.5046,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 6,
      "atr_pct": 2.26
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "平衡",
      "score": 6,
      "value": 36.41
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "平衡",
      "score": 4,
      "value": 0.0909
    },
    "kdj": {
      "d": 53.39,
      "j": 12.81,
      "k": 39.86,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "入貨中",
      "score": 8,
      "value": 63.34
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 2,
      "trend": "資金流出",
      "value": 3773660,
      "recentSlope": -201474,
      "previousSlope": 286860
    },
    "rsi": 66.26,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 339.4653,
      "position": "SAR喺價上",
      "distancePct": 2.4,
      "previousTrend": "下降"
    },
    "ma50": 305.3204,
    "macd": {
      "macd": 7.844424614144998,
      "trend": "中性偏多",
      "signal": 9.617478019414078,
      "histogram": -1.7730534052690796
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 6,
      "value": 329.568,
      "position": "連續1-2日>VWAP",
      "consecutiveAbove": 2
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "無力",
      "ratio": 0.89,
      "score": 4,
      "avgVolume": 581772,
      "currentVolume": 520640
    },
    "derived": {
      "ma20": 329.0015,
      "ma50": 305.3204,
      "prevClose": 331.66,
      "avgVolume10": 637484,
      "avgVolume20": 581772,
      "changePercent": -0.05,
      "avgVolumeForScore": 581772
    },
    "ma_cross": {
      "ma20": 329.0015,
      "ma50": 305.3204,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 328.253,
      "prevMa50": 303.994,
      "spreadPct": 7.76,
      "isVolumeBreakout": false
    },
    "bollinger": {
      "lower": 315.6745,
      "upper": 342.3285,
      "position": "上半部"
    },
    "rsi_short": 34.89,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 0.89
    }
  }
}

{
  "close": 331.5,
  "volume": 520640,
  "changePercent": -0.05
}